跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
DARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Vivanta Generics S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 28, 2021
Approval ID
278a33c2cc8a59ed
Company
Vivanta Generics S.R.O.
Type
Standard
Approval Details
Approval Id
278a33c2cc8a59ed
Drug Cima Aemps Name
DARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86483
Holder Company Name
Vivanta Generics S.R.O.
Marketing Company Name
Vivanta Generics S.R.O. Sucursal En Espana
Authorization Date
2021-12-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
600 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Vivanta Generics S.R.O.
Active Ingredients
DARUNAVIR
600 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 28, 2021
Approval ID
278a33c2cc8a59ed
Type
Standard
Back to CIMA-AEMPS Approvals
DARUNAVIR VIVANTA 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details